The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cost of Cancer Care: Issues and Implications
Abstract
Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospect Theory: An Analysis of Decision under Risk
Kahneman, D., & Tversky, A. (1979) · Econometrica · doi:10.2307/1914185 · Cited by 48,524
Prospect theory: An analysis of decision under risk
Kahneman, D., & Tversky, A. (1988) · Decision, Probability and Utility · doi:10.1017/cbo9780511609220.014 · Cited by 32,474
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Capps, L. (2003) · JAMA · doi:10.1001/jama.290.18.2487-b · Cited by 4,526
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE
Arrow, K. J. (2003) · Uncertain Times · doi:10.2307/j.ctv11sn34h.6 · Cited by 4,078
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,801
Uncertainty and The Welfare Economics of Medical Care
Arrow, K. J. (2001) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-26-5-851 · Cited by 1,467
Hoff, P. M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., Maroun, J., Walde, D., Weaver, C., Harrison, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2282 · Cited by 1,130
Grothey, A., Sargent, D., Goldberg, R. M., & Schmoll, H.-J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.037 · Cited by 1,070
Van Cutsem, E., Twelves, C., Cassidy, J., Allman, D., Bajetta, E., Boyer, M., Bugat, R., Findlay, M., Frings, S., Jahn, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4097 · Cited by 1,032
Racial Differences in the Treatment of Early-Stage Lung Cancer
Bach, P. B., Cramer, L. D., Warren, J. L., & Begg, C. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411606 · Cited by 994
The economics of moral hazard: comment
Pauly, M. V. (1982) · Readings in the Economics of Contract Law · doi:10.1017/cbo9780511528248.009 · Cited by 987
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Estimating The Cost Of New Drug Development: Is It Really $802 Million?
Adams, C. P., & Brantner, V. V. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.420 · Cited by 907
Newhouse, J. P., & Taylor, V. (1969) · Cited by 583
Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States
Meissner, H. I., Breen, N., Klabunde, C. N., & Vernon, S. W. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0678 · Cited by 571
Hadley, J. (2003) · Medical Care Research and Review · doi:10.1177/1077558703254101 · Cited by 494
Care without Coverage: Too Little, Too Late
Kilbourne, A. M. (2005) · PubMed Central · Cited by 461
The Price Tag on Progress — Chemotherapy for Colorectal Cancer
Schrag, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048143 · Cited by 436
Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment
Bickell, N. A., Wang, J. J., Oluwole, S., Schrag, D., Godfrey, H., Hiotis, K., Mendez, J., & Guth, A. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5799 · Cited by 363
Economics of New Oncology Drug Development
DiMasi, J. A., & Grabowski, H. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0803 · Cited by 348
The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending
Huskamp, H. A., Deverka, P. A., Epstein, A. M., Epstein, R. S., McGuigan, K. A., & Frank, R. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa030954 · Cited by 334
High and Rising Health Care Costs. Part 1: Seeking an Explanation
Bodenheimer, T. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-10-200505170-00010 · Cited by 303
Inappropriate Use of Hospitals in a Randomized Trial of Health Insurance Plans
Siu, A. L., Sonnenberg, F. A., Manning, W. G., Goldberg, G. A., Bloomfield, E. S., Newhouse, J. P., & Brook, R. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152005 · Cited by 286
The New Era of Medical Imaging — Progress and Pitfalls
Iglehart, J. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmhpr061219 · Cited by 270
Health Spending Projections Through 2015: Changes On The Horizon
Borger, C., Smith, S., Truffer, C., Keehan, S., Sisko, A., Poisal, J., & Clemens, M. K. (2006) · Health Affairs · doi:10.1377/hlthaff.25.w61 · Cited by 239
Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj308 · Cited by 227
Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients?
Jacobson, M., O’Malley, A. J., Earle, C. C., Pakes, J., Gaccione, P., & Newhouse, J. P. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.437 · Cited by 136
Increasing Health Insurance Costs and the Decline in Insurance Coverage
Chernew, M. E., Cutler, D., & Keenan, P. S. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00409.x · Cited by 134
Health Spending Projections Through 2013
Heffler, S., Smith, S. D., Keehan, S. P., et al. (2004) · Health Affairs · doi:10.1377/hlthaff.w4.79 · Cited by 134
European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies
Drummond, M., & Mason, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8956 · Cited by 120
Stevens, G. D., & Shi, L. (2003) · Medical Care Research and Review · doi:10.1177/1077558702250229 · Cited by 108
U.S. Health Spending Projections For 2004–2014
Heffler, S., Smith, S. D., Keehan, S. P., Borger, C., Clemens, M. K., & Truffer, C. J. (2005) · Health Affairs · doi:10.1377/hlthaff.w5.74 · Cited by 106
Implications of Pharmacogenomics for Drug Development and Clinical Practice
Ginsburg, G. S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2331 · Cited by 74
Treading water: Americans' access to needed medical care, 1997-2001.
Strunk, B. C., & Cunningham, P. J. (2002) · PubMed · Cited by 65
Gabel, J. R., Claxton, G., Holve, E., Pickreign, J. D., Whitmore, H., Dhont, K., Hawkins, S., & Rowland, D. (2003) · Health Affairs · doi:10.1377/hlthaff.22.5.117 · Cited by 63
Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs
Knudsen, A. B., McMahon, P. M., & Gazelle, G. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9202 · Cited by 51
Can Prospect Theory Explain Risk-Seeking Behavior by Terminally Ill Patients?
Rasiel, E. B., Weinfurt, K. P., & Schulman, K. A. (2005) · Medical Decision Making · doi:10.1177/0272989x05282642 · Cited by 44
Self-citationInterpreting the Economic Literature in Oncology
Grusenmeyer, P. A., & Wong, Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0738 · Cited by 38
Value of High-Cost Cancer Care: A Behavioral Science Perspective
Weinfurt, K. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9029 · Cited by 33
Ramsey, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9805 · Cited by 30
An Exploration of Relative Health Stock in Advanced Cancer Patients
Gaskin, D. J., Weinfurt, K. P., Castel, L. D., DePuy, V., Li, Y., Balshem, A. M., Benson, A. B., Burnett, C. B., Corbett, S. E., Marshall, J. L., et al. (2004) · Medical Decision Making · doi:10.1177/0272989x04271041 · Cited by 26
Self-citationTreatment Choices by Seriously III Patients
Gaskin, D. J., Kong, J., Meropol, N. J., Yabroff, K. R., Weaver, C. H., & Schulman, K. A. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800116 · Cited by 25
Self-citationThe Insurance Effect on Prescription Drug Expenditures Among the Elderly
Curtis, L. H., Law, A. W., Anstrom, K. J., et al. (2004) · Medical Care · doi:10.1097/01.mlr.0000124247.03660.09 · Cited by 16
Wolfgang, M. E. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4883-3_20 · Cited by 5
Cited by
Financial Hardships Experienced by Cancer Survivors: A Systematic Review
Altice, C. K., Banegas, M. P., Tucker-Seeley, R. D., & Yabroff, K. R. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw205 · Cited by 864
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Self-citationAmerican Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Self-citationSystemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 504
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama, Y., Takahashi, M., Hur, K., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt101 · Cited by 499
Metadata
- Authors
- Meropol, N. J., & Schulman, K. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-01-10
- Volume
- 25
- Issue
- 2
- Pages
- 180-186
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2150273386
- Cited by
- 351
- References
- 50
- FWCI
- 66.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.